Heat-killed Tsukamurella inchonensis reduces lipopolysaccharide-induced inflammatory responses in activated murine peritoneal macrophages

DOI:10.17221/144/2016-VETMEDCitation:Nofouzi K, Aghapour M, Baradaran B, Hamidian GH, Zare P, Stanford J, Ripley P, Tahapour K, Jafari Y, Shahbazfar A, Tukmechi A (2017): Heat-killed Tsukamurella inchonensis reduces lipopolysaccharide-induced inflammatory responses in activated murine peritoneal macrophages. Veterinarni Medicina, 62: 668-673.
download PDF

Tsukamurella inchonensis (T. inchonensis) is an aerobic species of Actinomycetales which has immunomodulatory activities when used as a suspension of killed bacilli. Here, the effects of T. inchonensis on lipopolysaccharide-induced inflammatory responses in mouse peritoneal macrophages have been examined. Peritoneal macrophages were harvested by lavaging with ice cold phosphate-buffered saline. Macrophages acquired from mice treated with different doses of T. inchonensis for seven days were cultured with 20 U/ml interferon-γ and 10 µg/ml lipopolysaccharide for in vivo assays. Nitrite levels were measured by using the diazotization method based on the Griess reaction, an indirect technique to determine nitric oxide (NO) production. T. inchonensis inhibited lipopolysaccharide-stimulated NO production in mouse peritoneal macrophages from mice previously exposed to concentrations of 108 and 5 × 107 CFU per flask. Also, T. inchonensis decreased lipopolysaccharide-induced production of pro-inflammatory cytokines, including interleukin-6 and tumor necrosis factor-α. Thus, it can be concluded that T. inchonensis is a powerful inhibitor of lipopolysaccharide-induced NO production in activated murine macrophages, and T. inchonensis may be useful as a novel agent for chemoprevention in inflammatory diseases.

References:
Azadmehr Abbas, Afshari Afshin, Baradaran Behzad, Hajiaghaee Reza, Rezazadeh Shamsali, Monsef-Esfahani Hamidreza (2009): Suppression of nitric oxide production in activated murine peritoneal macrophages in vitro and ex vivo by Scrophularia striata ethanolic extract. Journal of Ethnopharmacology, 124, 166-169 doi:10.1016/j.jep.2009.03.042
 
Beurel Eléonore, Jope Richard S (2009): Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain. Journal of Neuroinflammation, 6, 9- doi:10.1186/1742-2094-6-9
 
Beutler Bruce (1990): TNF in Pathophysiology: Biosynthetic Regulation. Journal of Investigative Dermatology, 95, S81-S84 doi:10.1111/1523-1747.ep12874797
 
Bozza Fernando A, Salluh Jorge I, Japiassu André M, Soares Marcio, Assis Edson F, Gomes Rachel N, Bozza Marcelo T, Castro-Faria-Neto Hugo C, Bozza Patrícia T (): Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Critical Care, 11, R49- doi:10.1186/cc5783
 
Cousens L. P., Orange J. S., Su H. C., Biron C. A. (1997): Interferon- /  inhibition of interleukin 12 and interferon-  production in vitro and endogenously during viral infection. Proceedings of the National Academy of Sciences, 94, 634-639 doi:10.1073/pnas.94.2.634
 
Davis Karen L, Martin Emil, Turko Illarion V, Murad Ferid (2001): N OVEL E FFECTS OF N ITRIC O XIDE. Annual Review of Pharmacology and Toxicology, 41, 203-236 doi:10.1146/annurev.pharmtox.41.1.203
 
Delgado M, Pozo D, Martinez C, Leceta J, Calvo JR, Ganea D, Gomariz RP (1999): Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-α production by macrophages: in vitro and in vivo studies. Journal of Immunology 162, 2358–2367.
 
Dinarello C. A. (1986): Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. Journal of Experimental Medicine, 163, 1433-1450 doi:10.1084/jem.163.6.1433
 
Gennari Roberto, Alexander J. Wesley (1995): Anti-interleukin-6 antibody treatment improves survival during gut-derived sepsis in a time-dependent manner by enhancing host defense. Critical Care Medicine, 23, 1945-1953 doi:10.1097/00003246-199512000-00002
 
Goodman M. N. (1994): Interleukin-6 Induces Skeletal Muscle Protein Breakdown in Rats. Experimental Biology and Medicine, 205, 182-185 doi:10.3181/00379727-205-43695
 
Howard Kenneth A, Paludan Søren R, Behlke Mark A, Besenbacher Flemming, Deleuran Bent, Kjems Jørgen (2009): Chitosan/siRNA Nanoparticle–mediated TNF-α Knockdown in Peritoneal Macrophages for Anti-inflammatory Treatment in a Murine Arthritis Model. Molecular Therapy, 17, 162-168 doi:10.1038/mt.2008.220
 
Jang Daniel, Murrell George A.C (1998): Nitric Oxide in Arthritis. Free Radical Biology and Medicine, 24, 1511-1519 doi:10.1016/S0891-5849(97)00459-0
 
Kopydlowski KM, Salkowski CA, Cody MJ, Rooijen NV, Major J, Hamilton TA, Vogel SN (1999): Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo. Journal of Immunology 163, 1537–1544.
 
Lu DH, Tang CH, Chang CH, Maa MC, Fang SH, Hsu YM, Lin YH, Lin CJ, Lee WC, Lin HJ, Lee CH, Lai CH (2011): Helicobacter pylori attenuates lipopolysaccharide-induced nitric oxide production by murine macrophages. Journal of Innate Immunology 18, 406–417.
 
Luiking Yvette C, Engelen Mariëlle PKJ, Deutz Nicolaas EP (2010): Regulation of nitric oxide production in health and disease. Current Opinion in Clinical Nutrition and Metabolic Care, 13, 97-104 doi:10.1097/MCO.0b013e328332f99d
 
Moncada S, Erusalimsky JD (2002): Does nitric oxide modulates mitochondrial energy generation and apoptosis? Nature Reviews Molecular Cell Biology 3, 214–220.
 
Moore K. J., Andersson L. P., Ingalls R. R., Monks B. G., Li R., Arnaout M. A., Golenbock D. T., Freeman M. W. (2000): Divergent Response to LPS and Bacteria in CD14-Deficient Murine Macrophages. The Journal of Immunology, 165, 4272-4280 doi:10.4049/jimmunol.165.8.4272
 
Morrison D C, Ryan J L (1987): Mechanisms. Annual Review of Medicine, 38, 417-432 doi:10.1146/annurev.me.38.020187.002221
 
Mosser D. M. (): The many faces of macrophage activation. Journal of Leukocyte Biology, 73, 209-212 doi:10.1189/jlb.0602325
 
Murad Ferid (1996): Signal Transduction Using Nitric Oxide and Cyclic Guanosine Monophosphate. JAMA: The Journal of the American Medical Association, 276, 1189- doi:10.1001/jama.1996.03540140077033
 
Nagahira Asako, Nagahira Kazuhiro, Murafuji Hidenobu, Abe Keiichi, Magota Koji, Matsui Masashi, Oikawa Shinzo (2001): Identification of a Novel Inhibitor of LPS-Induced TNF-α Production with Antiproliferative Activity in Monocyte/Macrophages. Biochemical and Biophysical Research Communications, 281, 1030-1036 doi:10.1006/bbrc.2001.4476
 
Nofouzi K., Aghapour M., Hamidian Gh, Katiraee F., Stanford J., Ripley P. (2016): Oral administration of heat killed Tsukamurella inchonensis enhances immune responses and intestinal function in mice. Veterinární Medicína, 61, 681-688 doi:10.17221/82/2016-VETMED
 
Ohnishi Megumi, Kimura Sadao, Yamazaki Masatoshi, Abe Shigeru, Yamaguchi Hideyo (1994): Characterization of Immunological Activity of a Low Toxicity Antitumor Lipopolysaccharide from Bordetella pertussis. Microbiology and Immunology, 38, 733-739 doi:10.1111/j.1348-0421.1994.tb01849.x
 
Remick D. G., Bolgos G., Copeland S., Siddiqui J. (2005): Role of Interleukin-6 in Mortality from and Physiologic Response to Sepsis. Infection and Immunity, 73, 2751-2757 doi:10.1128/IAI.73.5.2751-2757.2005
 
Ren Xiaodan, Hogaboam Cory, Carpenter Audra, Colletti Lisa (2003): Stem cell factor restores hepatocyte proliferation in IL-6 knockout mice following 70% hepatectomy. Journal of Clinical Investigation, 112, 1407-1418 doi:10.1172/JCI17391
 
Riedemann N. C., Neff T. A., Guo R.-F., Bernacki K. D., Laudes I. J., Sarma J. V., Lambris J. D., Ward P. A. (2003): Protective Effects of IL-6 Blockade in Sepsis Are Linked to Reduced C5a Receptor Expression. The Journal of Immunology, 170, 503-507 doi:10.4049/jimmunol.170.1.503
 
Semmler Alexander, Frisch Christian, Debeir Thomas, Ramanathan Mutiah, Okulla Thorsten, Klockgether Thomas, Heneka Michael T. (2007): Long-term cognitive impairment, neuronal loss and reduced cortical cholinergic innervation after recovery from sepsis in a rodent model. Experimental Neurology, 204, 733-740 doi:10.1016/j.expneurol.2007.01.003
 
Stanford John, Stanford Cynthia (2012): Mycobacteria and their world. International Journal of Mycobacteriology, 1, 3-12 doi:10.1016/j.ijmyco.2012.01.001
 
Tarrés María Cristina, Gayol María del Carmen, Picena Juan Carlos, Alet Nicolás, Bottasso Oscar, McIntyre Graham, Stanford Cynthia, Stanford John (2012): Beneficial effects of immunotherapy with extracts derived from Actinomycetales on rats with spontaneous obesity and diabetes. Immunotherapy, 4, 487-497 doi:10.2217/imt.12.37
 
TEJADA-SIMON MARIA VICTORIA, USTUNOL ZEYNEP, PESTKA JAMES J. (1999): Ex Vivo Effects of Lactobacilli, Streptococci, and Bifidobacteria Ingestion on Cytokine and Nitric Oxide Production in a Murine Model. Journal of Food Protection, 62, 162-169 doi:10.4315/0362-028X-62.2.162
 
Tewari K., Nakayama Y., Suresh M. (2007): Role of Direct Effects of IFN-  on T Cells in the Regulation of CD8 T Cell Homeostasis. The Journal of Immunology, 179, 2115-2125 doi:10.4049/jimmunol.179.4.2115
 
Tsujinaka T, Fujita J, Ebisui C, Yano M, Kominami E, Suzuki K, Tanaka K, Katsume A, Ohsugi Y, Shiozaki H, Monden M (1996): Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice.. Journal of Clinical Investigation, 97, 244-249 doi:10.1172/JCI118398
 
Vyas D. (2005): Early antibiotic administration but not antibody therapy directed against IL-6 improves survival in septic mice predicted to die on basis of high IL-6 levels. AJP: Regulatory, Integrative and Comparative Physiology, 289, R1048-R1053 doi:10.1152/ajpregu.00312.2005
 
Xu Xiaojuan, Yasuda Michiko, Mizuno Masashi, Ashida Hitoshi (2012): β-Glucan from Saccharomyces cerevisiae reduces lipopolysaccharide-induced inflammatory responses in RAW264.7 macrophages. Biochimica et Biophysica Acta (BBA) - General Subjects, 1820, 1656-1663 doi:10.1016/j.bbagen.2012.06.015
 
download PDF

© 2018 Czech Academy of Agricultural Sciences